FDA Approves Date Rape Drug in Treating Sleep Disorder
The Food and Drug Association (FDA) recently approved the dangerous date rape drug GHB for its first legal use as a medical product in treating a complication of narcolepsy, according to the Associated Press. Despite repeated warnings issued by the FDA and others about the use of GHB in date rape, Xyrem, GHB’s brand name, will now be sold under restricted conditions.
The drug first became notorious as a date rape drug in the 1990s – it became popular for its colorless, odorless quality and ability to knock people out. Reports of GHB being slipped into a woman’s drink to render her immobile or unconscious have since multiplied on college campuses across the country. In the March-April 2000 edition of the FDA’s consumer magazine, a 2000 Glamour magazine survey was cited in which 19 percent of female college students said they knew someone who was the victim of the date-rape drug GHB. “The survey helps to confirm GHB's unfortunate standing as a common date-rape drug along with the infamous Rohypnol and others,” the article reads. In addition, the US Drug Enforcement Agency has cited GHB in at least 58 deaths and 5,700 overdoses since 1990.
GHB was originally developed as a surgical anesthetic, but was quickly pulled off the market because of serious side effects such as depressed breathing, coma, and death. In the 1990s, GHB became known as a relatively inexpensive party drug, a performance enhancer for athletes and bodybuilders, and a sex enhancer. GHB is also known as liquid ecstasy, cherry meth, Easy Lay and Georgia homeboy.
Xyrem, distributed by Orphan Medical Inc., will be used to treat cataplexy, a complication of narcolepsy that is characterized by muscle weakness that can, in its most severe forms, cause victims to collapse during waking hours, according to the Associated Press.
Media Resources: Associated Press, 7/18/02; FDA Consumer Magazine March/April 2000
1/23/2015 #HeForShe Campaign Launches Pilot Effort Aimed at Institutional Equality - The United Nations' gender equality campaign #HeForShe has launched a new program called IMPACT 10X10X10.
United Nations Goodwill Ambassador Emma Watson, together with UN Women Executive DirectorPhumzile Mlambo-Ngcuka, introduced the one-year pilot effort aimed at encouraging corporations, universities, and governments to play an active role in enhancing women's empowerment and equality in Davos, Switzerland today at the World Economic Forum.
"Women need to be equal participants in our homes, societies, in our governments, and in our workplaces," Watson said.
First introduced in September, HeForShe is a solidarity movement that calls on men and boys to confront gender inequalities that face women and girls globally. . . .
1/22/2015 BREAKING: House to Vote on Abortion Coverage Ban - After they were forced to scrap plans for a 20-week abortion ban, House Republican leaders decided late last night to instead ram through a vote today on a different extreme anti-abortion bill.
House Republicans are now pushing HR 7, a bill promoted as a ban on federal funding of abortion that would actually prevent women from using their own money to purchase health insurance that includes abortion care. . . .
1/22/2015 House Cancels Abortion Ban After GOP Congresswomen Drop Support - House Republicans cancelled plans to vote on a 20-week ban on abortion after Republican Congresswomen removed their names publicly as co-sponsors of the bill.
The vote on the unconstitutional 20-week ban had originally been scheduled for today, the anniversary of Roe v. . . .